Amino acid replacement: P2303L. This mutation is within the highly conserved area of the kinase domain.
C13012397T
P2293L | Tor-PA; P2294L | Tor-PB
P2303L
Position of mutation on reference sequence inferred by FlyBase curator. Difference between annotated and reported sites of amino acid substitution due to authors reported CDS being 10aa longer.
larval salivary gland & nucleus (with mTork17004)
The number of nuclei in the segmental border muscle is slightly reduced compared to wild type in mutant embryos.
Mutant embryos have thinner muscles than normal and unfused myoblasts are present.
Cells in Tor2L1 mutant clones in the eye are 0.26 times the size of their heterozygous neighbours.
mTor2L1 has decreased cell size | third instar larval stage | somatic clone - Minute background phenotype, suppressible by Pten117/Pten117
mTor2L1/mTor2L19 has decreased body size | larval stage phenotype, suppressible | partially by REPTORKO
mTor2L1 has decreased cell size | third instar larval stage | somatic clone - Minute background phenotype, non-suppressible by RhebEP50.084-loxP/Scer\GAL4Tub.PU
mTor2L1 has decreased cell size | somatic clone phenotype, non-suppressible by Tsc129/Tsc129
mTor2L1/Tor[+] is a suppressor of increased cell size | somatic clone phenotype of Tsc129
mTor2L1/Tor[+] is a suppressor of lethal | recessive | larval stage phenotype of Tsc129
mTor2L1 has larval fat cell | third instar larval stage | somatic clone - Minute background phenotype, suppressible by Pten117/Pten117
RhebEP50.084, Scer\GAL4GMR.PF, mTor2L1/Tor[+] has ommatidium phenotype, suppressible | partially by S6k[+]/S6kl-1
mTor2L1 has larval fat cell | third instar larval stage | somatic clone - Minute background phenotype, non-suppressible by RhebEP50.084-loxP/Scer\GAL4Tub.PU
mTor2L1/Tor[+] is a suppressor | partially of ommatidium phenotype of RhebEP50.084, Scer\GAL4GMR.PF
The large size and disorganisation of ommatidia in Scer\GAL4GMR.PF/+; RhebEP50.084/+ flies is partially dominantly suppressed by Tor2L1 (ommatidia are 1.27 times wild-type size, and slightly disorganised).
The first instar larval lethality due to Tsc129 is partially suppressed by heterozygosity for Tor2L1 : 31% (n = 193) of Tor2L1/+ Tsc129/Tsc129 animals survive to the pupal stage. The increased cell size seen in somatic clones of Tsc129 in the eye is partially suppressed in a Tor2L1 heterozygous background: the resulting clone cells are 1.3X wild-type size, compared to 1.9X for Tsc129 somatic clone cells in a wild-type background. Cells in Tor2L1; Tsc129 double mutant somatic clones are approximately 0.25 times the size of their heterozygous neighbours - i.e.- have little or no size difference with Tor2L1 somatic clone cells.
The second instar lethality of homozygous Tsc1Q87X is rescued to adulthood (18.5%) or pupal stages (82.5%) by heterozygosity for Tor2L1. The second instar lethality of homozygous Tsc1Q87X is rescued to adulthood (62%) or pupal stages (93%) by heterozygosity for both S6kl-1 and Tor2L1. The rescued animals are slightly larger than wild-type flies, with overall patterning appearing normal. The rescued females are semi-fertile when crossed to wild-type males, whereas the rescued males are fully fertile when crossed to wild-type females.